These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 17123107

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
    Dabbs DJ, Chivukula M, Carter G, Bhargava R.
    Mod Pathol; 2006 Nov; 19(11):1506-11. PubMed ID: 16941011
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O, Wang SA, Hileeto D.
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
    Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.
    Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
    [Abstract] [Full Text] [Related]

  • 12. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
    Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F.
    Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
    [Abstract] [Full Text] [Related]

  • 13. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S, Wang J, Bourne P, Yang Q, Tang P.
    Ann Clin Lab Sci; 2007 Aug; 37(2):127-34. PubMed ID: 17522367
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.
    Pol J Pathol; 2005 Aug; 56(3):107-10. PubMed ID: 16334976
    [Abstract] [Full Text] [Related]

  • 15. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP, Cohen C, Hanley KZ, Li XB.
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [Abstract] [Full Text] [Related]

  • 16. Prognostic markers in triple-negative breast cancer.
    Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO.
    Cancer; 2007 Jan 01; 109(1):25-32. PubMed ID: 17146782
    [Abstract] [Full Text] [Related]

  • 17. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A, Sussman ZM, Lawson D, Cohen C.
    Breast J; 2012 Sep 01; 18(5):399-405. PubMed ID: 22882580
    [Abstract] [Full Text] [Related]

  • 18. [Basal-like breast cancers: clinicopathological features and outcome].
    De Brot M, Soares FA, Stiepcich MM, Cúrcio VS, Gobbi H.
    Rev Assoc Med Bras (1992); 2009 Sep 01; 55(5):529-34. PubMed ID: 19918651
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.
    Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P, Komoltri C, Watcharahirun S, Sa-Nguanraksa D.
    Asian Pac J Cancer Prev; 2014 Sep 01; 15(3):1187-92. PubMed ID: 24606439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.